权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Beta Cell Regeneration in Adult Pancreatic Islets

成人胰岛的β细胞再生

基本信息

批准号：
7251881
负责人：
GLADYS N. TEITELMAN
金额：
$ 22.19万
依托单位：
SUNY DOWNSTATE MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2005
资助国家：
美国
起止时间：
2005-07-18 至 2010-06-30
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/7251881
关键词：
Acinar Cell Address Adult Alpha Cell Amylases Appearance B-Lymphocytes Beta Cell Biological Markers Biological Models Cell Differentiation process Cell Lineage Cell Transplantation Cell model Cells Cessation of life Characteristics Dose Embryo Endocrine Future Galactosidase Genetic Genetically Engineered Mouse Glucagon Glucose Transporter Goals In Situ Insulin Insulin-Dependent Diabetes Mellitus Islet Cell Islets of Langerhans Knowledge Label Laboratories Modeling Molecular Mus Natural regeneration Numbers Pancreas Pancreatectomy Pharmaceutical Preparations Phenotype Play Population Process Protocols documentation Regulation Research Personnel Role Somatostatin Source Stem cells Stimulus Streptozocin Structure of beta Cell of islet System Testing Toxic effect Toxin Transgenic Mice Work base blood glucose regulation design in vivo regeneration islet novel precursor cell programs response restoration trait transdifferentiation

项目摘要

DESCRIPTION (provided by applicant): Destruction of the insulin-producing beta cells leads to IDDM. The present goal of our work is to ascertain whether islets of adults contain beta precursor cells and to later establish protocols that will promote beta cell neogenesis. We developed a novel system in which new beta cells (NBC's) are induced to differentiate from putative beta cell precursors. Following depletion of existing beta cells by streptozotocin (SZ), a specific beta cell toxin, we found that cells expressing the phenotype characteristic of embryonic beta cells differentiated in islets and that this step was followed by the appearance of NBC's. Moreover, the restoration of normoglycemia by insulin therapy dramatically increased beta cell neogenesis. We now propose to identify the source of the NBC's. In specific aim #1, we will test whether IN+ cells that reappear in islets of SZ-treated mice following restoration of normoglycemia are NBC's or "old" beta cells that survived the effect of the toxin. To do this, we will test whether beta cell neogenesis occurs in mice in which "old" beta cells are identified by the presence of a molecular marker. In the specific aim #2, we will seek to determine whether the NBC's are generated by non-beta cells of the pancreas. To accomplish this goal, we will examine the process of beta cell neogenesis following SZ and insulin treatment in normoglycemic mice in which glucagon and amylase cells and the cells they generate are permanently labeled. These approaches could lend proof to the hypothesis that intra-islet precursors play an important role in beta cell regeneration in vivo in this and other models of IDDM.

描述（由申请人提供）：破坏产生胰岛素的β细胞导致IDDM。我们目前的工作目标是确定成人胰岛是否含有β前体细胞，并随后建立促进β细胞新生的方案。我们开发了一种新的系统，其中新的β细胞（NBC）被诱导从推定的β细胞前体分化。在通过链脲佐菌素（SZ）（一种特异性β细胞毒素）耗尽现有β细胞之后，我们发现表达胚胎β细胞的表型特征的细胞在胰岛中分化，并且该步骤之后是NBC的出现。此外，通过胰岛素治疗恢复正常血糖显著增加了β细胞新生。我们现在建议确定NBC的来源。在具体目标#1中，我们将测试在恢复正常血糖后在SZ处理的小鼠的胰岛中重新出现的IN+细胞是否是NBC或在毒素作用下存活的“旧”β细胞。为了做到这一点，我们将测试β细胞新生是否发生在小鼠中，其中“老”β细胞通过分子标记的存在来识别。在具体目标#2中，我们将寻求确定NBC是否由胰腺的非β细胞产生。为了实现这一目标，我们将研究正常血糖小鼠中SZ和胰岛素治疗后β细胞新生的过程，其中胰高血糖素和淀粉酶细胞及其产生的细胞被永久标记。这些方法可以提供证据的假设，胰岛内前体细胞在体内β细胞再生中发挥重要作用，在这个和其他模型的胰岛素依赖型糖尿病。